White Guide and Orange Guide Formatting Project - Pfizer

Responding to Requests for Funding by P&T Committee Members
Orange Guide – Chapter 7: P&T Committee Interactions
Q. What if, while I am giving a presentation on a Pfizer product under formulary
review, a P&T Committee member asks for a grant or charitable contribution?
Should I schedule a separate meeting to explain Pfizer's process for considering
these requests?
A. No. You must never affirmatively raise the topic of providing a grant or
charitable contribution to a P&T Committee member, but if the member makes
a specific unsolicited inquiry about it you may address it by doing the following:
Stating that, at the conclusion of your product discussion, you can
provide information about the procedures for submitting a request to
Pfizer;
Stating that a decision to provide the requested funds will in no way be
influenced by the P&T Committee member's status in making formulary
decisions; and
Explaining that the decision on whether to provide requested funds will
be made by an independent multi-disciplinary group and will not be
impacted by the pending formulary decision.
Formal Product Presentations to P&T Committees
Who May Present?
P&T Committees often ask pharmaceutical manufacturers for product information and invite them to
present data that supports putting their products on formulary.
Any knowledgeable colleague (or qualified consultant approved by Pfizer Headquarters) can appear
before a P&T Committee on Pfizer's behalf. Most often, Medical Colleagues (RMRS or MOS) appear
before these Committees. However, in some settings, other colleagues may present information.
What Information May Colleagues Present?
There are differences in the types of information colleagues may present at these meetings, especially
regarding off-label information or new data that is not approved for product promotion. The key to
130
Rev. 09/12
Page 8 of 11